PortfoliosLab logoPortfoliosLab logo
MED vs. OSUR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MED vs. OSUR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medifast, Inc. (MED) and OraSure Technologies, Inc. (OSUR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MED achieves a 3.18% return, which is significantly lower than OSUR's 71.90% return. Over the past 10 years, MED has underperformed OSUR with an annualized return of -7.79%, while OSUR has yielded a comparatively higher -4.53% annualized return.


MED

1D
-0.18%
1M
-12.47%
YTD
3.18%
6M
-2.74%
1Y
-22.01%
3Y*
-49.36%
5Y*
-46.41%
10Y*
-7.79%

OSUR

1D
-2.12%
1M
15.24%
YTD
71.90%
6M
72.61%
1Y
38.67%
3Y*
-6.63%
5Y*
-15.45%
10Y*
-4.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MED vs. OSUR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MED
Medifast, Inc.
3.18%-39.39%-73.79%-38.34%-42.31%9.36%86.18%-9.73%82.11%72.33%
OSUR
OraSure Technologies, Inc.
71.90%-32.96%-55.98%70.12%-44.53%-17.90%31.82%-31.25%-38.07%114.81%

Correlation

The correlation between MED and OSUR is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Dec 31, 1993

0.18

The correlation between MED and OSUR shifts across timeframes, from 0.12 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MED:

$121.29M

OSUR:

$289.85M

EPS

MED:

-$1.82

OSUR:

-$0.73

PS Ratio

MED:

0.35

OSUR:

3.53

Total Revenue (TTM)

MED:

$346.10M

OSUR:

$85.12M

Gross Profit (TTM)

MED:

$242.70M

OSUR:

$33.04M

EBITDA (TTM)

MED:

-$3.86M

OSUR:

-$47.07M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MED vs. OSUR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED
MED Risk / Return Rank: 1919
Overall Rank
MED Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
MED Sortino Ratio Rank: 1717
Sortino Ratio Rank
MED Omega Ratio Rank: 1919
Omega Ratio Rank
MED Calmar Ratio Rank: 2020
Calmar Ratio Rank
MED Martin Ratio Rank: 2121
Martin Ratio Rank

OSUR
OSUR Risk / Return Rank: 6464
Overall Rank
OSUR Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
OSUR Sortino Ratio Rank: 6666
Sortino Ratio Rank
OSUR Omega Ratio Rank: 6262
Omega Ratio Rank
OSUR Calmar Ratio Rank: 6363
Calmar Ratio Rank
OSUR Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MED vs. OSUR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and OraSure Technologies, Inc. (OSUR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MEDOSURDifference
Sharpe ratioReturn per unit of total volatility

-1.33

Sortino ratioReturn per unit of downside risk

-2.08

Omega ratioGain probability vs. loss probability

0.93

1.17

-0.24

Calmar ratioReturn relative to maximum drawdown

-0.59

0.99

-1.58

Martin ratioReturn relative to average drawdown

-1.00

2.22

-3.22

MED vs. OSUR - Sharpe Ratio Comparison

The current MED Sharpe Ratio is -0.53, which is lower than the OSUR Sharpe Ratio of 0.80. The chart below compares the historical Sharpe Ratios of MED and OSUR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MED vs. OSUR - Drawdown Comparison

The maximum MED drawdown since its inception was -98.40%, which is greater than OSUR's maximum drawdown of -90.75%. Use the drawdown chart below to compare losses from any high point for MED and OSUR.


Loading charts...

Drawdown Indicators


MEDOSURDifference

Max Drawdown

Largest peak-to-trough decline

-98.40%

-90.75%

-7.65%

Max Drawdown (1Y)

Largest decline over 1 year

-37.39%

-39.37%

+1.98%

Max Drawdown (3Y)

Largest decline over 3 years

-90.91%

-74.73%

-16.18%

Max Drawdown (5Y)

Largest decline over 5 years

-96.29%

-84.23%

-12.06%

Max Drawdown (10Y)

Largest decline over 10 years

-96.76%

-90.75%

-6.01%

Current Drawdown

Current decline from peak

-96.26%

-81.76%

-14.50%

Average Drawdown

Average peak-to-trough decline

-50.87%

-56.72%

+5.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.13%

17.46%

+4.67%

Volatility

MED vs. OSUR - Volatility Comparison

The current volatility for Medifast, Inc. (MED) is 10.40%, while OraSure Technologies, Inc. (OSUR) has a volatility of 20.12%. This indicates that MED experiences smaller price fluctuations and is considered to be less risky than OSUR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDOSURDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.40%

20.12%

-9.72%

Volatility (6M)

Calculated over the trailing 6-month period

31.76%

34.50%

-2.74%

Volatility (1Y)

Calculated over the trailing 1-year period

41.83%

48.62%

-6.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.28%

54.97%

-9.69%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.73%

56.94%

-9.21%

Dividends

MED vs. OSUR - Dividend Comparison

Neither MED nor OSUR has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
MED
Medifast, Inc.
0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%
OSUR
OraSure Technologies, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MED vs. OSUR - Financials Comparison

This section allows you to compare key financial metrics between Medifast, Inc. and OraSure Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20222023202420252026
76.04M
27.93K
(MED) Total Revenue
(OSUR) Total Revenue
Values in USD except per share items

MED vs. OSUR - Profitability Comparison

The chart below illustrates the profitability comparison between Medifast, Inc. and OraSure Technologies, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
68.1%
42.3%
Portfolio components
MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.

OSUR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, OraSure Technologies, Inc. reported a gross profit of 11.80K and revenue of 27.93K. Therefore, the gross margin over that period was 42.3%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.

OSUR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, OraSure Technologies, Inc. reported an operating income of -23.18K and revenue of 27.93K, resulting in an operating margin of -83.0%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.

OSUR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, OraSure Technologies, Inc. reported a net income of -22.38K and revenue of 27.93K, resulting in a net margin of -80.1%.


Frequently Asked Questions


MED and OSUR have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OSUR has higher volatility (20.12%) compared to MED (10.40%). In terms of maximum drawdown, MED dropped -98.40% vs OSUR's -90.75%.

OSUR currently has the higher Sharpe Ratio (0.80 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MED and OSUR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer